{"symbol":"JNJ","fiscalQuarter":"Q2-2011","reportDate":"2011-07-19","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2011","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Down 0.55%","keyNumbers":[{"metric":"EPS","actual":"$1.28","expected":"N/A","surprise":"+3.56%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on innovation and operational efficiency."],"summary":"Management expressed satisfaction with the EPS results, highlighting ongoing efforts in innovation. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Johnson & Johnson's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell slightly by 0.55%, suggesting that investors may have been looking for more comprehensive guidance or revenue details. The lack of revenue data and future guidance could have contributed to the stock's downward movement.","metaDescription":"Johnson & Johnson (JNJ) Q2 2011 earnings: EPS beat by 3.56%. Stock down 0.55%. Full breakdown."}}